Acadian Asset Management
TENX icon

Acadian Asset Management’s Tenax Therapeutics TENX Stock Holding History

Acadian Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,502
Closed -$71K – 2234
2026
Q1 		$71K Buy
+4,502
New +$60.9K ﹤0.01% 1810
2023
Q1 		– Sell
-756
Closed -$133K – 1973
2022
Q4 		$133K Buy
+756
New +$166K ﹤0.01% 1374

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Acadian Asset Management's TENX Position: Q2 2026 in Review

Acadian Asset Management sold out of Tenax Therapeutics (TENX) in Q2 2026, closing a stake of 4,502 shares — an estimated $71K sold.

Acadian Asset Management first reported a position in TENX in Q4 2022 and held it in 2 quarters. The position peaked at $133K in Q4 2022. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Acadian Asset Management reported no remaining Tenax Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Acadian Asset Management sold 4,502 Tenax Therapeutics shares in Q2 2026, an estimated $71K.
  • Acadian Asset Management first reported a position in Tenax Therapeutics in Q4 2022 and held it in 2 quarters.
  • Acadian Asset Management's Tenax Therapeutics position peaked at $133K in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.